Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.11
67.33
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Rhythm Pharmaceuticals Inc
Wall Street
Price Targets
RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
RYTM
is 71.68 USD
with a low forecast of 58.58 USD and a high forecast of 88.2 USD.
RYTM Last Price Targets
Rhythm Pharmaceuticals Inc
The latest public price target was made on Nov 6, 2024 by
Corinne Jenkins
from
Goldman Sachs
,
who expects
RYTM
stock to
drop by 1%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Corinne Jenkins
Goldman Sachs
|
59
USD
Downside 1% |
2 weeks ago
Nov 6, 2024
|
Rhythm Pharmaceuticals (RYTM) PT Raised to $59 at Goldman Sachs
StreetInsider
|
Alan Carr
Needham
|
64
USD
Upside 7% |
2 weeks ago
Nov 6, 2024
|
Rhythm Pharmaceuticals (RYTM) PT Raised to $64 at Needham
StreetInsider
|
|
Raghuram Selvaraju
H.C. Wainwright
|
64
USD
Upside 7% |
2 months ago
Sep 18, 2024
|
Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright
TheFly
|
Jonathan Wolleben
JMP Securities
|
64
USD
Upside 7% |
2 months ago
Sep 17, 2024
|
JMP Securities Starts Rhythm Pharmaceuticals (RYTM) at Market Outperform
StreetInsider
|
|
Alan Carr
Needham
|
55
USD
Downside 8% |
3 months ago
Jul 25, 2024
|
Rhythm Pharmaceuticals (RYTM) PT Raised to $55 at Needham
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RYTM's stock price target?
Price Target
71.68
USD
According to Wall Street analysts, the average 1-year price target for
RYTM
is 71.68 USD
with a low forecast of 58.58 USD and a high forecast of 88.2 USD.
What is Rhythm Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
63%
The
compound annual growth rate
of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is
63%.
You don't have any saved screeners yet
